There is growing evidence of applicability of the hypothesis of the mutant selection window (MSW), i.e., the range between the MIC and the mutant prevention concentration (MPC), within which the enrichment of resistant mutants is most probable. However, it is not clear if MPC-based pharmacokinetic variables are preferable to the respective MIC-based variables as interstrain predictors of resistance. To examine the predictive power of the ratios of the area under the curve (AUC 24 ) to the MPC and to the MIC, the selection of ciprofloxacin-resistant mutants of three Klebsiella pneumoniae strains with different MPC/MIC ratios was studied. Each organism was exposed to twice-daily ciprofloxacin for 3 days at AUC 24 /MIC ratios that provide peak antibiotic concentrations close to the MIC, between the MIC and the MPC, and above the MPC. Resistant K. pneumoniae mutants were intensively enriched at an AUC 24 /MIC ratio of 60 to 360 h (AUC 24 /MPC ratio from 2.5 to 15 h) but not at the lower or higher AUC 24 /MIC and AUC 24 /MPC ratios, in accordance with the MSW hypothesis. AUC 24 /MPC and AUC 24 /MIC relationships with areas under the time courses of ciprofloxacin-resistant K. pneumoniae (AUBC M ) were bell shaped. These relationships predict highly variable "antimutant" AUC 24 /MPC ratios (20 to 290 h) compared to AUC 24 /MIC ratios (1,310 to 2,610 h). These findings suggest that the potential of the AUC 24 /MPC ratio as an interstrain predictor of K. pneumoniae resistance is lower than that of the AUC 24 /MIC ratio.
A n increasing number of reports on the isolation of resistant pathogens (1, 2) combined with a weak antibiotic pipeline suggests that optimization of antibiotic therapy should be aimed at the suppression of resistance (3, 4) . In this regard, dynamic models that mimic antimicrobial pharmacokinetics in vitro have been proven to be a useful tool in predicting the amplification of resistant mutants at clinically achievable antibiotic concentrations (5) . Using these models, bell-shaped relationships have been established between the emergence of resistance to fluoroquinolones and the ratios of 24-hour area under the concentration-time curve (AUC 24 ) to the MIC (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Such relationships have been reported with moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin, the investigational fluoroquinolone ABÒ492, pazufloxacin, tosufloxacin, and garenoxacin against Staphylococcus aureus (6) (7) (8) (14) (15) (16) ; moxifloxacin against Streptococcus pneumoniae (12, 13) ; garenoxacin against Klebsiella pneumoniae (15) ; ciprofloxacin and moxifloxacin against Pseudomonas aeruginosa (11, 12) ; and ciprofloxacin, marbofloxacin, and enrofloxacin against Escherichia coli (9, 10, 17) . In some of these studies (6-15, 17, 18) , changes in susceptibility of antibiotic-exposed bacteria and/or their enrichment with resistant mutants was observed at fluoroquinolone concentrations above the MIC but below the mutant prevention concentration (MPC), i.e., inside the mutant selection window (MSW) but not outside the MSW, in accordance with the MSW hypothesis (19, 20) . However, the potential of AUC 24 /MIC and AUC 24 /MPC ratios as interstrain predictors of bacterial resistance has been examined only infrequently (8, 10, (16) (17) (18) 21) .
To compare the abilities of AUC 24 /MPC and AUC 24 /MIC ratios to predict interstrain thresholds that restrict mutant enrichment, ciprofloxacin-resistant mutants of three K. pneumoniae strains with various MPC/MIC ratios were studied over a wide range of AUC 24 /MIC ratios simulated in an in vitro dynamic model.
MATERIALS AND METHODS
Antimicrobial agent, bacterial strains, and susceptibility testing. Ciprofloxacin powder was purchased from AppliChem BioChemica Chemical Synthesis Services (Darmstadt, Germany).
Three clinical isolates of K. pneumoniae, 1885, 1145, and 185, with different ciprofloxacin MICs (1, 0.5, and 0.125 g/ml, respectively) and MPCs (8, 12 , and 8 g/ml, respectively) were selected for the study. The MICs were determined prior to, during, and after 3-day simulated treatments with ciprofloxacin. Susceptibility testing was performed at least in duplicate by broth microdilution techniques (22) at 24 h postexposure with organisms grown in Ca 2ϩ -and Mg 2ϩ -supplemented Mueller-Hinton broth (MHB) at an inoculum size of 10 6 CFU/ml. The MPCs were determined as described elsewhere (8) . Briefly, the tested microorganisms were cultured in MHB and incubated for 24 h. Then, the suspension was centrifuged (4,000 ϫ g for 10 min) and resuspended in MHB to yield a concentration of ϳ10 10 CFU/ml. A series of agar plates containing known ciprofloxacin concentrations was then inoculated with ϳ10 10 CFU of K. pneumoniae. The inoculated plates were incubated for 48 h at 37°C and screened visually for growth. To estimate the MPC, logarithms of bacterial numbers were plotted against antibiotic concentrations. MPC was taken as the point where the plot intersected the lower limit of detection (log CFU/milliliter ϭ 1).
In vitro dynamic model and simulated pharmacokinetic profiles. A previously described dynamic model (23) was used in the study. The con-cordance between measured and designed concentrations of ciprofloxacin has been reported elsewhere (9) . Briefly, the model consisted of two connected flasks, one containing fresh MHB and the other with a magnetic stirrer, the central unit, with the same broth containing a bacterial culture plus antibiotic. Peristaltic pumps circulated fresh nutrient medium to the flasks and from the central 100-ml unit at a flow rate of 17.3 ml/h. The system was filled with sterile MHB and placed in an incubator at 37°C. The central unit was inoculated with an 18-hour culture of K. pneumoniae. After a 2-hour incubation, the resulting exponentially growing cultures reached approximately 10 8 CFU/ml, and ciprofloxacin solutions were injected into the central unit at 12-h intervals. The duration of the experiments was at least 72 h.
A series of monoexponential profiles that mimic twice-daily dosing of ciprofloxacin with a half-life (t 1/2 ) of 4 h was simulated for 3 consecutive days. The simulated t 1/2 represented weighted means of values reported for humans, 3.2 to 5.0 h (24) . The simulated pharmacokinetic profiles were designed to provide 24-hour ratios of area under the curve (AUC 24 ) to the MIC from 15 to 2,880 h (corresponding to an AUC 24 range from 15 to 2,880 g · h/ml [0.7-to 131-g · h/ml range of ciprofloxacin clinical doses against K. pneumoniae 1885]) and from 7.5 to 2,880 h with K. pneumoniae 1145 and 185 (corresponding to an AUC 24 range from 3.75 to 1,440 and from 0.9 to 360 g · h/ml, respectively [0.2-to 66-and 0.04-to 16.4-g · h/ml range of the clinical dose, respectively]).
Quantitation of antibiotic effect on susceptible and resistant subpopulations. In each experiment, bacterium-containing medium from the central unit of the model was sampled every 24 h to determine bacterial concentrations throughout the observation period. One-hundredmicroliter samples were serially diluted if necessary, in order to account for antibiotic carryover prior to plating, thereby reducing the antibiotic concentration below the MIC of the drug. Samples were spirally plated onto Mueller-Hinton agar (MHA) plates without antibiotic ("0ϫ MIC") and those containing 4ϫ, 8ϫ, and 16ϫ MIC of ciprofloxacin using the Easy Spiral Pro system (Interscience, St. Nom, France). Colonies were counted by an automated colony counter (Interscience Scan 1200; Interscience, St. Nom, France).
The lower limit of counting susceptible and resistant cells was 200 CFU/ml (equivalent to 20 colonies per plate); the lower limit of quantification of resistant mutants was 10 CFU/ml (equivalent to at least one colony per plate). To reveal changes in susceptibility of ciprofloxacinexposed bacterial cultures, MICs were reassessed every 24 h during the experiment and after the simulated treatment. To confirm the enhanced ciprofloxacin resistance in isolates with established MIC elevations, repetitive MIC testing was performed after several passages on antibiotic-free medium.
Based on time-kill data, the area between the cutoff level at 10 8 CFU/ml and the time-kill curve (ABBC [25] ) was calculated. The ABBClog AUC 24 /MIC curve was fitted by the sigmoid function:
where Y is ABBC; x is log(AUC 24 /MIC); Y 0 and a are the minimal and maximal values of the antimicrobial effect, respectively; x 0 is x corresponding to a/2; and b is a parameter reflecting sigmoidicity. To delineate AUC 24 /MIC and AUC 24 /MPC relationships with resistance, areas under the bacterial mutant concentration-time curves (AUBC M s [8] ) were determined for subpopulations resistant to 4ϫ, 8ϫ, and 16ϫ MIC of antibiotic from the beginning of treatment to 72 h, corrected for the areas under the lower limit of quantification over the same time interval. To reveal changes in susceptibility of ciprofloxacinexposed bacterial cultures, MICs were reassessed every 24 h during the experiment and after antibiotic exposures (MIC final ). Each sample from the central compartment was plated on Mueller-Hinton agar (MHA). After 18 to 24 h of incubation, a suspension of isolated colonies was made in MHB to achieve an 0.5 McFarland turbidity standard. Susceptibility was evaluated by the microdilution technique (22 
where Y is AUBC M or MIC final /MIC initial , x is log(AUC 24 /MIC) or log(AUC 24 /MPC), Y 0 is the minimal value of Y, x 0 is log(AUC 24 /MIC) or log(AUC 24 /MPC) that corresponds to the maximal value of Y, and a, b, and are parameters.
Determination of "antimutant" AUC 24 /MIC and AUC 24 /MPC ratios. To determine the AUC 24 /MIC and AUC 24 /MPC ratios that protect against the enrichment of mutants (antimutant ratios), points belonging to the descending portion of the AUBC M -AUC 24 /MIC and AUBC M -AUC 24 /MPC curves were used. The AUBC M s were plotted against the respective AUC 24 /MIC ratios and AUC 24 /MPC ratios. The antimutant ratio was taken as the point where the regression line reaches the level of AUBC M of 30 log(CFU/ml) · h.
where Y is AUBC M , x is AUC 24 /MIC or AUC 24 /MPC ratio, Y 0 is the minimal value of Y, and a is a parameter.
Mechanisms of resistance.
Nucleotide sequences of the quinoloneresistance-determining regions (QRDRs) of gyrA and parC genes were determined for both parental strains and mutants with enhanced ciprofloxacin resistance as previously described (26, 27) with some modifications. The PCR and sequencing primers were redesigned based on alignment of all K. pneumoniae gyrA and parC gene sequences available from GenBank. The original forward primer, gyrA6 (5=-CGACCTTGCGAGA GAAAT-3=), described by Weigel et al. (26) , was used in combination with the modified primer, gyrAR2 (5=-CCTTCAATGCTGATGTCTTCA-3=); the parC forward and reverse primers (27) were extended by 2 bases at the 3= end (parC-F2, 5=-TACGTGATCATGGACAGGGC-3=) and shortened by one base at the 5=-end (parC-R2, 5=-CCACTTCCCGCAGGTTG-3=), respectively. Bacterial genomic DNA was isolated using the InstaGene matrix kit (Bio-Rad Laboratories Inc., Hercules, CA). Amplified fragments were purified by exonuclease I and shrimp alkaline phosphatase treatment (Thermo Scientific Fermentas, Vilnius, Lithuania) and were sequenced on both strands using the same primers as those for PCR, the BigDye Terminator v3.1 cycle sequencing kit, and the ABI Prism 310 genetic analyzer (Applied Biosystems, Foster City, CA). Sequences obtained were compared with those previously reported for gyrA and parC genes of K. pneumoniae ATCC 43816 (GenBank nucleotide sequence accession no. APWN00000000.1).
RESULTS
Time courses of simulated ciprofloxacin concentrations, related to MIC, and ciprofloxacin-exposed K. pneumoniae grown without antibiotic (0ϫ MIC) and on medium containing, for example, 4ϫ MIC of ciprofloxacin at three characteristic AUC 24 /MIC ratios are shown in Fig. 1 . As seen in the left column, small and transient, if any, reductions in the number of susceptible K. pneumoniae cells were observed at the lowest AUC 24 /MIC ratio (15 h). Mutants resistant to 4ϫ MIC of ciprofloxacin were enriched starting from the second day of treatment with each of the studied organisms. At the AUC 24 /MIC ratio of 60 h (middle column in Fig. 1 ), both killing of susceptible cells and enrichment of resistant K. pneumoniae were more pronounced than at the lower AUC 24 /MIC ratio. At least with K. pneumoniae 1145, ciprofloxacin-susceptible cells were completely replaced by resistant mutants by the end of treatment. With an increase in the AUC 24 /MIC ratio to 720 h (right column in Fig. 1 ), the numbers of susceptible cells decreased significantly except for K. pneumoniae 1145 (maximal reduction of 3 log CFU/ml). Although resistant mutants were enriched beginning from the 3rd to 4th day of treatment, their final numbers were 1.1 to 2.4 log CFU/ml smaller than at the intermediate simulated AUC 24 /MIC ratio.
Mutants resistant to 8ϫ and 16ϫ MIC were isolated with each ciprofloxacin-exposed organism at each AUC 24 /MIC ratio except for the lack of growth of K. pneumoniae 185 mutants resistant to 16ϫ MIC at an AUC 24 /MIC of 15 h. Time courses of the more resistant mutants were similar to those observed with the mutant resistant to 4ϫ MIC of ciprofloxacin (data not shown). As a whole, the higher the resistance level the less pronounced was the respective mutant's growth. The enrichment of resistant mutants at AUC 24 /MIC ratios of 15 and 60 h was accompanied by concomitant MIC elevations. The enhanced ciprofloxacin resistance in these isolates was confirmed by repetitive MIC testing after several passages on antibiotic-free medium. With K. pneumoniae 1885 and 1145, the maximal ratio of MIC final to MIC initial (14 and 8, respectively) was observed at an AUC 24 /MIC ratio of 60 h, and that with K. pneumoniae 185 was observed at an AUC 24 /MIC ratio of 720 h (MIC final /MIC initial ϭ 14). More detailed MIC final /MIC initial data obtained over a wider range of simulated AUC 24 /MIC ratios are discussed below.
To determine the mechanisms of decreased ciprofloxacin susceptibility in mutants, partial nucleotide sequences of gyrA (nucleotides 21 to 605 with respect to the translation start site) and parC (nucleotides 82 to 585 with respect to the translation start site) genes spanning the entire quinolone-resistance-determining regions (QRDRs) were analyzed. The sequences of the parental strains and mutant strains were identical and contained no missense mutations compared to the wild-type K. pneumoniae ATCC 43816 (GenBank nucleotide sequence accession no. APWN00000000.1).
To delineate concentration-resistance relationships, the AUBC M s were plotted against AUC 24 /MIC and AUC 24 /MPC ratios. tant to 4ϫ, 8ϫ, and 16ϫ MIC of ciprofloxacin. With each organism, AUBC M versus AUC 24 /MIC and AUC 24 /MPC curves were bell shaped. The AUBC M increased with an increase in the AUC 24 /MIC or AUC 24 /MPC ratio, reaching a maximum followed by a subsequent decrease in numbers of resistant mutants. The maximal amplification of mutants resistant to 4ϫ, 8ϫ, and 16ϫ MIC of ciprofloxacin was bacterial strain specific, much more pronounced for K. pneumoniae 185 and 1145 than for K. pneumoniae 1885. At the lower levels of resistance (4ϫ and 8ϫ MIC), maximal AUBC M s for resistant mutants of the studied organisms differ by 1.3 to 1.8 orders of magnitude, whereas with the highest level of resistance (16ϫ MIC) the strain-specific difference in the maximal AUBC M s was 2.5-fold. Regardless of bacterial strain, AUBC M s that reflect amplification of mutants resistant to 4ϫ MIC of ciprofloxacin were more pronounced than those with mutants resistant to 8ϫ and especially 16ϫ MIC.
Unlike maximal AUBC M s, AUC 24 /MIC and AUC 24 /MPC ratios that correspond to maximums on the bell-shaped curves did not depend on the level of resistance, but they were strain specific. Maximal amplification of resistant K. pneumoniae 1145 occurred at a lower AUC 24 /MIC ratio (60 h) than that for K. pneumoniae 1885 (60 to 120 h) and especially K. pneumoniae 185 (180 to 360 h). The respective AUC 24 /MPC ratios were 2.5, 7.6 to 15, and 2.8 to 5.6 h. Also, bacterial strain-specific differences were inherent in the antimutant AUC 24 /MIC and AUC 24 /MPC ratios determined for individual organisms ( Table 1 ). As seen in Table 1 24 /MPC combined data on the three K. pneumoniae mutants resistant to 4ϫ MIC of ciprofloxacin (Fig. 3, upper plot) with relatively high r 2 s (0.76 and 0.72, respectively). Less clear correlations were found for mutants resistant to 8ϫ MIC (0.63 and 0.60, respectively) and 16ϫ MIC (0.61 and 0.55, respectively) (data not shown). As seen in Fig. 3 , the greatest enrichment of mutants resistant to 4ϫ MIC of ciprofloxacin was seen at 90 h (AUC 24 /MIC ratio) and 5 h (AUC 24 /MPC ratio), i.e., within the ranges established for individual organisms (60 to 360 h and 2.5 to 15 h, respectively).
To determine the antimutant AUC 24 /MIC and AUC 24 /MPC ratios more precisely, only points on the descending branch of the bell were considered (Fig. 3, lower plot) . Although AUC 24 /MPC and AUC 24 /MIC relationships with the AUBC M were similar, a linear function (equation 3) fits AUC 24 /MIC data combined for the three K. pneumoniae strains better than the AUC 24 /MPC ratio: (Fig.  4) . These relationships were bell shaped, similarly to the respective AUC 24 /MIC or AUC 24 /MPC relationships with the AUBC M described above. As seen in the left plot in Fig. 4 , the maximal MIC final elevations were observed at the intermediate AUC 24 /MIC ratios (180 to 360 h), whereas at the lower and higher AUC/ MIC ratios the MIC final s did not increase. MIC final /MIC initial ratio versus AUC 24 /MIC ratio showed good correlation (r 2 of 0.75), comparable to AUBC M -AUC 24 /MIC or AUBC M -AUC 24 /MPC relationships. However, the MIC final /MIC initial -AUC 24 /MPC relationship, shown in the right plot in Fig. 4 , was described with significantly lower r 2 (0.43) because of pronounced scattering of the points. As seen in Fig. 4 , the greatest losses in susceptibility occurred at the AUC 24 /MIC ratio of 300 h and AUC 24 /MPC ratio of 8.5 h. The respective antimutant AUC 24 /MIC and AUC 24 /MPC ratios, at which the MIC final /MIC initial ratio was 1, were 2,560 and 300 h.
Pronounced individual variability was inherent also in killing of susceptible subpopulations of K. pneumoniae exposed to ciprofloxacin (Fig. 5) . Using combined data on the three organisms, a sigmoid function (equation 1) fits the ABBC versus AUC 24 /MIC ratio with an r 2 of 0.78.
DISCUSSION
Aimed at examination of the AUC 24 /MPC and AUC 24 /MIC ratios as interstrain predictors of bacterial resistance, this study demonstrates applicability of the MSW hypothesis to fluoroquinoloneresistant K. pneumoniae. With each of three clinical isolates, the maximal amplification of mutants resistant to 4ϫ, 8ϫ, and 16ϫ MIC of ciprofloxacin was observed when antibiotic concentrations fell into the MSW for most of the dosing interval, and both AUC 24 /MIC and AUC 24 /MPC relationships with resistance expressed by the population analysis data (AUBC M ) or susceptibility testing (ratio of the postexposure MIC to preexposure MIC) were bell shaped. These observations are consistent with earlier findings reported in studies with fluoroquinolones (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) .
Findings obtained in the present study predict the antimutant AUC 24 /MIC ratios for K. pneumoniae strains 1885, 1145, and 185 (2,320, 2,610, and 1,310 h, respectively) that are much higher than the respective clinically attainable AUC 24 /MIC ratios (22, 44 , and 176 h, respectively). The same trend also was seen in our recent study with ciprofloxacin against four P. aeruginosa strains (11): antimutant AUC 24 /MIC ratios (220 to 1,100 h) were higher than the respective clinically attainable AUC 24 /MIC ratios (44 and 176 h). In contrast, in our studies with E. coli (9) , despite relatively high antimutant AUC 24 /MIC ratios (720 to 1,440 h), these ratios can be achieved at clinically attainable exposures (AUC/MIC ratios of 2,750 and 1,375 h).
Despite pronounced stratification of AUBC M versus AUC 24 / MIC or AUC 24 /MPC curves seen with individual organisms, it appeared possible to establish bacterial strain-independent AUC 24 / MIC or AUC 24 /MPC relationships with resistance using com-bined data with all three K. pneumoniae strains. Similar relationships were established between the MIC final /MIC initial ratio and AUC 24 /MIC and AUC 24 /MPC ratios. However, AUC 24 /MIC and AUC 24 /MPC ratios that correspond to the greatest loss in susceptibility were shifted toward higher values compared to those that correspond to the greatest AUBC M . A similar shift was reported with two of four strains in our study with ciprofloxacin-exposed P. aeruginosa (11) .
As in our recent study with ciprofloxacin against E. coli (10), to test significant levels of K. pneumoniae resistance, we chose mutants resistant to 4ϫ, 8ϫ, and 16ϫ MIC, ignoring more abundant nontarget (e.g., efflux) mutants resistant to 2ϫ MIC of ciprofloxacin because exposure of bacteria to twice their MICs can almost be regarded as a positive control (28) . In the present study, we did not identify any changes in nucleotide sequences of gyrA and parC QRDRs of ciprofloxacin-resistant K. pneumoniae mutants compared to those of parental or reference strains, suggesting that the enhancement of resistance was likely due to altered drug accumulation, although mutations causing resistance to fluoroquinolones in Enterobacteriaceae most often occur in the QRDR of the primary target gene, gyrA (9, (29) (30) (31) . Additional mutations that further increase resistance to fluoroquinolones may occur in the secondary target gene, parC (29) (30) (31) , and, in K. pneumoniae, in various regulatory genes that affect the expression of efflux pumps, e.g., AcrAB (32-34), and major porins, OmpK35 and OmpK36 (35, 36) , leading to decreased accumulation of the drug in bacterial cells.
In conclusion, findings obtained in the present study are in support of the MSW hypothesis that explains the bell shape of the AUBC M versus AUC 24 /MIC and AUC 24 /MPC curves. However, highly variable AUC 24 /MPC thresholds call into question the reliability of their interstrain predictions of the enrichment of K. pneumoniae mutants. From this point of view, the AUC 24 /MIC ratio should be preferred to the AUC 24 /MPC ratio for predictions of the emergence of K. pneumoniae resistance. Similar conclusions were drawn in studies with ciprofloxacin-exposed E. coli (9, 10) and P. aeruginosa (11) . In fact, a priori expectations of better predictive force of the AUC 24 /MPC ratio were confirmed only with fluoroquinolone-exposed S. aureus (5, 8) .
Further studies with other bacterial species are needed to provide a more complete understanding of AUC 24 /MIC and AUC 24 / MPC ratios as potential predictors of the enrichment of resistant mutants.
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